T 1661/14 (IL-13 antagonists for treating fibroma/GENETICS INSTITUTE) of 28.02.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T166114.20190228
- Date of decision
- 28 February 2019
- Case number
- T 1661/14
- Online on
- 22 July 2019
- Petition for review of
- -
- Application number
- 00928591.7
- IPC class
- A61K 38/19A61K 38/17A61P 43/00A61P 37/00C07K 19/00A61K 38/20A61K 39/395C07K 14/715A61K 38/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment of Fibrosis by Antagonism of IL-13 and IL-13 Receptor Chains
- Applicant name
- Genetics Institute, LLC
Government of the United States Of America, as
represented by the Secretary, Department Of Health
and Human Services - Opponent name
- Schlich, George
Genentech, Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Inventive step - all requests (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.